ROPES WEALTH ADVISORS LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROPES WEALTH ADVISORS LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$278,000
-11.7%
2,3500.0%0.05%
-2.0%
Q3 2021$315,000
-17.1%
2,3500.0%0.05%
-16.7%
Q2 2021$380,000
+196.9%
2,3500.0%0.06%
+200.0%
Q4 2020$128,000
+1728.6%
2,350
+571.4%
0.02%
+1900.0%
Q3 2020$7,0000.0%3500.0%0.00%0.0%
Q2 2020$7,000
+75.0%
3500.0%0.00%0.0%
Q1 2020$4,000
-20.0%
3500.0%0.00%0.0%
Q4 2019$5,0000.0%3500.0%0.00%0.0%
Q3 2019$5,000
-77.3%
350
-74.1%
0.00%
-80.0%
Q2 2019$22,000
+266.7%
1,350
+285.7%
0.01%
+150.0%
Q1 2019$6,0003500.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders